skip to content

Press Releases

Emmaus Life Sciences Provides SEC Reporting UpdateAugust 10, 2021

2020 Financial Statements Restated to Reflect Increase in Net Income Attributable to Change in Equity Method Investment in Japanese Affiliate. Amended and Restated Form 10-K Includes Complete Restated Financial Statements and Currently Dated, Unqualified Audit Report.

Read More